Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Journal of Biomedicine & Biotechnology
|
December 29, 2010
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors
Mario Federico, Luigi Bagella
Cells
|
September 26, 2025
Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies
Stefano Zoroddu, Luigi Bagella
World Journal of Clinical Oncology
|
April 16, 2016
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
Irene Marchesi, Luigi Bagella
Clinical Epigenetics
|
August 10, 2021
PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis
Stefano Zoroddu, Irene Marchesi, Luigi Bagella
Cell Cycle (Georgetown, Tex.)
|
February 6, 2014
Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis
Irene Marchesi, Antonio Giordano, Luigi Bagella
Journal of Cellular Physiology
|
October 13, 2017
A new parameter of growth inhibition for cell proliferation assays
Francesco P Fiorentino, Luigi Bagella, Irene Marchesi
Journal of Cellular Biochemistry
|
June 3, 2006
Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle
Luigi Bagella, Cristina Giacinti, Cristiano Simone, et al.
Oncogene
|
May 31, 2002
Physical interaction between pRb and cdk9/cyclinT2 complex
Cristiano Simone, Luigi Bagella, Cristiana Bellan, et al.
Journal of Cellular Physiology
|
August 22, 2007
Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy
Antonio Giordano, Alessandra Rossi, Gaetano Romano, et al.
International Journal of Molecular Sciences
|
March 13, 2025
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target
Fabio Sias, Stefano Zoroddu, Rossana Migheli, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Journal of Biomedicine & Biotechnology
|
December 29, 2010
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors
Mario Federico, Luigi Bagella
Cells
|
September 26, 2025
Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies
Stefano Zoroddu, Luigi Bagella
World Journal of Clinical Oncology
|
April 16, 2016
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
Irene Marchesi, Luigi Bagella
Clinical Epigenetics
|
August 10, 2021
PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis
Stefano Zoroddu, Irene Marchesi, Luigi Bagella
Cell Cycle (Georgetown, Tex.)
|
February 6, 2014
Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis
Irene Marchesi, Antonio Giordano, Luigi Bagella
Journal of Cellular Physiology
|
October 13, 2017
A new parameter of growth inhibition for cell proliferation assays
Francesco P Fiorentino, Luigi Bagella, Irene Marchesi
Journal of Cellular Biochemistry
|
June 3, 2006
Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle
Luigi Bagella, Cristina Giacinti, Cristiano Simone, et al.
Oncogene
|
May 31, 2002
Physical interaction between pRb and cdk9/cyclinT2 complex
Cristiano Simone, Luigi Bagella, Cristiana Bellan, et al.
Journal of Cellular Physiology
|
August 22, 2007
Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy
Antonio Giordano, Alessandra Rossi, Gaetano Romano, et al.
International Journal of Molecular Sciences
|
March 13, 2025
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target
Fabio Sias, Stefano Zoroddu, Rossana Migheli, et al.
Page
of 6